Delivery Order SPE2DB22D1106-SPE2DB24FESJ1
Award Date
5/16/24
Potential Completion Date
5/17/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,359,392 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The $1,937.74 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen, one of the largest pharmaceutical distribution companies...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,415,474 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm fixed price of $1,542.47 and a period of performance ending on April 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,442.25 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,176,783 units of Fluticasone Propionate HFA 220 MCG 12GM. The contract has a ceiling value of $2,318.50 and a performance period through April 8, 2024. This award is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, worth $8,948.68, is for the supply of 4,565,285,694 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The award has an ultimate completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a $19,013.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,860,781 units of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. This delivery order contract is part of a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of medical...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the provision of 4,564,801,845 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,805.45 firm fixed price delivery order has a completion date of June 5, 2024 and is not set aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The award, valued at $1,232.03, has a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,148,082 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has a ceiling value of $4,633.76 and a period of performance through April 3, 2024. This order was issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...